SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study

GENE THERAPY · Published 2026-07-29 · DOI 10.1038/s41434-026-00635-z

Free full text

Authors (19)

Lena Dorsheimer, Joana Rita Ferreira, Bojing Wang, Rebecca Bohnert, Rashade Haynes II, Sabine Kaiser, Andreas Neerincx, Corinna Smolarek, Louise Delsing, Benoit Fischer, Stefanie Könen, Andreas Schulz, Kyle L. Kolaja, Ridhirama Bhuwania, Connie L. Chen, Lucilia Pereira Mouriès, Mick Fellows, Silvana Libertini, Myriam Lemmens

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Dorsheimer, L., Ferreira, J., Wang, B., et al. (2026). SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study. GENE THERAPY. https://doi.org/10.1038/s41434-026-00635-z

Related articles